US EditionRongchang Biopharma's Tetasip for Myasthenia Gravis Is Granted Orphan Drug Designation by the European Commission
Summary by Macau Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Yantai, China, June 17, 2025 /PRNewswire/ -- Recently, Rongchang Biopharma (688331.SH/09995.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
